Skip to content

Oral Hyoscine Butyl Bromide With Cervical Lidocaine Cream in Reducing Pain During Hysterosalpingography

Randomized Clinical Trial of Oral Hyoscine Butyl Bromide With Cervical Lidocaine Cream in Reducing Pain During Hysterosalpingography

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02710305
Acronym
HBTB
Enrollment
140
Registered
2016-03-16
Start date
2016-04-30
Completion date
2016-12-31
Last updated
2017-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Relief

Brief summary

hysterosalpingography is a diagnosis procedure in the evaluation of infertile women and considered to be the traditional and the gold standard in the assessment of the patency of the fallopian tubes. The major disadvantage of hysterosalpingography is pain. In a study reported the patients complained of moderate to severe pain during the procedure. It is reported that some patients undergoing hysterosalpingography was more stressful and anxiety and effect on pain scores.

Interventions

DRUGoral hyoscine butyl bromide tablets plus lidocaine cream

patients will take oral hyoscine butyl bromide 30 minutes before the procedure plus lidocaine anesthetic cream placed into their cervix immediately before the procedure

DRUGoral placebo tablets plus placebo cream

patients will take oral placebo 30 minutes before the procedure plus placebo cream placed into their cervix immediately before the procedure

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

• The infertile women who indicated for HSG

Exclusion criteria

* contraindications to Hyoscine or lidocaine * known sensitivity to contrast media * abnormal uterine bleeding * genital tract infection * suspected pregnancy

Design outcomes

Primary

MeasureTime frame
Mean pain score during HSGintraoperative

Secondary

MeasureTime frame
Mean pain score after HSG30 minutes
rate of side effects30 minutes

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026